Official UK procurement notice
DNA Extraction - Low throughput systems
Authority: NHS Blood and Transplant (Central government)·Consortium: 2 public authorities
What is being bought
Published requirement descriptionDNA Extraction - Low throughput systems
CPV: Diagnostic kits · Medical equipments
The lotProcurement structure
single lot · no lot value publishedLot #1The requirement is for low throughput systems which extract human DNA from whole blood…Awarded
The requirement is for low throughput systems which extract human DNA from whole blood and other tissues to carry out a range of DNA-based diagnostic tests. Please see II.2.4 for detailed description.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- Price
Procedure terms & legal framework
From the official record- Procedure method
- Restricted procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Yes
- First published
- 25 Mar 2021, 22:56 GMT
- Last source update
- 1 Dec 2022, 15:32 GMT
- FTS notice number
2022/S 000-034093- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-029f83Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
How it was run
Official noticeTender documents are also served through a separate tool: http://health.atamis.co.uk ↗
- Submission deadline
- 24 Mar 2022, 17:00 GMT
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
Timeline
2 Aug 2021 → 28 Feb 2023 · 5 dates- Next notice expected2 Aug 2021, 00:00 BST
- Invitations to tender expected18 Feb 2022
- Submission deadline24 Mar 2022, 17:00 GMT
- Notice published1 Dec 2022, 15:32 GMT
- Bids must remain valid until28 Feb 2023, 23:59 GMT
Notice history
6 events · 3 releases on Find a Tender · since 18 Feb 2022- Published value published: £3,800,00018 Feb 2022, 17:34 GMT
- Status changed to active18 Feb 2022, 17:34 GMT
- Procurement method changed18 Feb 2022, 17:34 GMT
- Deadline published: 24 Mar 2022, 17:00 GMT18 Feb 2022, 17:34 GMT
- Buyer details updated18 Feb 2022, 17:34 GMT
- Status changed to complete1 Dec 2022, 15:32 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Qiagen Limited | £1,937,000 † | — | Awarded |
Contracts
Contract 034093-2022-1 · Qiagen Limited
- Signed
- 28 Nov 2022
- Value
- £1,937,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 2bids | — | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- NHS Blood and TransplantContracting authorityBody governed by public lawHealth
Dispute resolution & review bodies
- The High CourtMediation bodyReview bodyReview contact point
Bidders & participating suppliers
1 commercial party on the notice- QIAGEN LTDAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria